Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,263,495
+$780,924 QoQ
Shares Held
247,569
+0.5% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 354 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $404,338,249 across 60 Biotechnology names. ACAD ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in ACAD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,263,495 | 247,569 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,482,571 | 246,297 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,042,389 | 226,222 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,688,000 | 172,821 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $767,264 | 35,571 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,114,390 | 187,501 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,769,527 | 150,928 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,492,519 | 97,043 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $549,769 | 33,832 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $484,678 | 26,213 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $265,946 | 8,494 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $132,562 | 6,361 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $98,793 | 4,125 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $57,156 | 3,037 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $60,352 | 3,689 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $72,704 | 3,115 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $43,335 | 2,609 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $72,491 | 1,356 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $55,935 | 1,356 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $171,535 | 4,060 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||